ED Sharpe, DG Day, CJ Beischel, JS Rhodes, … - British Journal of Ophthalmology, 2004 - bjo.bmj.com Methods: In this double masked, multicentre, prospective, crossover comparison
33 subjects were randomised to brimonidine purite or dorzolamide for the first 4
week treatment period after a 4 week washout. Subjects began the opposite ... Cited by 11 - Related articles - BL Direct - All 9 versions
AGP Konstas, CH Karabatsas, N Lallos, N … - Ophthalmology, 2005 - Elsevier Subjects were randomized to brimonidine purite or dorzolamide, each given twice
daily, for the first 6-week treatment period after a 6-week latanoprost run-in.
Subjects began the opposite treatment for the second 6-week period after a ... Cited by 19 - Related articles - All 13 versions
JT Whitson, C Henry, B Hughes, DA Lee, S … - Journal of Glaucoma, 2004 - journals.lww.com Skip Navigation Links Home > April 2004 - Volume 13 - Issue 2 > Comparison of
the Safety and Efficacy of Dorzolamide 2% and... ... This study was supported
by Glaucoma Research and Education Foundation, via an unrestricted research ... Cited by 14 - Related articles - BL Direct - All 2 versions
C Carrasco Font, A Arias Puente, MC Garcia … - Archivos de la Sociedad Española de Oftalmología, 2004 - SciELO Brasil SciELO - Scientific Electronic Library Online Browse SciELO, SciELO Library
Error Detector An unexpected error occurred in SciELO servers. ... Cited by 3 - Related articles - Cached - BL Direct - All 3 versions
ED Sharpe, DG Day, CJ Beischel, JS Rhodes, … - The British Journal of Ophthalmology, 2004 - ukpmc.ac.uk Results: The baseline diurnal IOP was 22.9 (SD 2.8) for brimonidine purite and
22.2 (SD 2.4) mm Hg for dorzolamide. The trough IOP following 4 weeks of therapy
was 21.0 (SD 3.7) for brimonidine purite and 21.0 (SD 3.1) mm Hg for ... Related articles
DG Day, DA Hollander - Current Medical Research and Opinion®, 2008 - informahealthcare.com Objective: To evaluate the efficacy and tolerability of brimonidine purite 0.1%
in comparison to brinzolamide 1% when used as adjunctive therapy to latanoprost
0.005% in patients with glaucoma or ocular hypertension. Methods: ... Cited by 4 - Related articles - All 5 versions
[CITATION] Alphagan Rm/Betaxolol Clinical Success Study Group. Comparison of the clinical success and …
DA Lee, JA Gornbein - Journal of Glaucoma, 2001 - journals.lww.com Cited Here...: Post hoc analysis of a multicenter, 2-month, open-label,
prospective, clinical trial in which 2,335 patients received brimonidine as
monotherapy, replacement therapy, or combination therapy. Patients who ... Cited by 26 - Related articles - BL Direct - All 3 versions
WC Stewart, ED Sharpe, TS Harbin, SA Pastor … - American journal of ophthalmology, 2000 - Elsevier RESULTS: Baseline intraocular pressure for all 40 subjects (76 eyes) was 24.1 ±
2.0 mm Hg. This study found that the 8:00 trough intraocular pressure after 6
weeks of therapy for dorzolamide was 20.7 ± 3.1 mm Hg and for brimonidine ... Cited by 41 - Related articles - BL Direct - All 8 versions
KN Sall, LJ Greff, LR Johnson-Pratt, PT … - Ophthalmology, 2003 - Elsevier Presented in part at the Association for Research in Vision and Ophthalmology
Annual Meeting, Fort Lauderdale, Florida, May 2001; at the American Academy of
Ophthalmology Annual Meeting, New Orleans, Louisiana, November 2001; at the ... Cited by 22 - Related articles - All 4 versions
